211 related articles for article (PubMed ID: 34047506)
1. Feasibility of Novel Three-Dimensional Magnetic Resonance Fingerprinting of the Prostate Gland: Phantom and Clinical Studies.
Han D; Choi MH; Lee YJ; Kim DH
Korean J Radiol; 2021 Aug; 22(8):1332-1340. PubMed ID: 34047506
[TBL] [Abstract][Full Text] [Related]
2. Quantitative longitudinal mapping of radiation-treated prostate cancer using MR fingerprinting with radial acquisition and subspace reconstruction.
Yu VY; Otazo R; Wu C; Subashi E; Baumann M; Koken P; Doneva M; Mazurkewitz P; Shasha D; Zelefsky M; Cervino L; Cohen O
Magn Reson Imaging; 2023 Sep; 101():25-34. PubMed ID: 37015305
[TBL] [Abstract][Full Text] [Related]
3. Free-Breathing Abdominal Magnetic Resonance Fingerprinting Using a Pilot Tone Navigator.
Huang SS; Boyacioglu R; Bolding R; MacAskill C; Chen Y; Griswold MA
J Magn Reson Imaging; 2021 Oct; 54(4):1138-1151. PubMed ID: 33949741
[TBL] [Abstract][Full Text] [Related]
4. Toward magnetic resonance fingerprinting for low-field MR-guided radiation therapy.
Mickevicius NJ; Kim JP; Zhao J; Morris ZS; Hurst NJ; Glide-Hurst CK
Med Phys; 2021 Nov; 48(11):6930-6940. PubMed ID: 34487357
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Repeatability and Reproducibility of MR Fingerprinting in Phantoms and in Prostatic Tissue.
Lo WC; Bittencourt LK; Panda A; Jiang Y; Tokuda J; Seethamraju R; Tempany-Afdhal C; Obmann V; Wright K; Griswold M; Seiberlich N; Gulani V
Magn Reson Med; 2022 Oct; 88(4):1818-1827. PubMed ID: 35713379
[TBL] [Abstract][Full Text] [Related]
6. Three-Dimensional Magnetic Resonance Fingerprinting in Neonates: Quantifying Regional Difference and Maturation in the Brain.
Yu N; Kim JY; Han D; Kim SY; Lee HM; Kim DH; Kim HG
Invest Radiol; 2022 Jan; 57(1):44-51. PubMed ID: 34101674
[TBL] [Abstract][Full Text] [Related]
7. Quantitative imaging metrics derived from magnetic resonance fingerprinting using ISMRM/NIST MRI system phantom: An international multicenter repeatability and reproducibility study.
Shridhar Konar A; Qian E; Geethanath S; Buonincontri G; Obuchowski NA; Fung M; Gomez P; Schulte R; Cencini M; Tosetti M; Schwartz LH; Shukla-Dave A
Med Phys; 2021 May; 48(5):2438-2447. PubMed ID: 33690905
[TBL] [Abstract][Full Text] [Related]
8. Temperature dependence, accuracy, and repeatability of T
Statton BK; Smith J; Finnegan ME; Koerzdoerfer G; Quest RA; Grech-Sollars M
Magn Reson Med; 2022 Mar; 87(3):1446-1460. PubMed ID: 34752644
[TBL] [Abstract][Full Text] [Related]
9. Accuracy, repeatability, and reproducibility of T
Wicaksono KP; Fushimi Y; Nakajima S; Sakata A; Okuchi S; Hinoda T; Oshima S; Otani S; Tagawa H; Urushibata Y; Nakamoto Y
Eur Radiol; 2023 Apr; 33(4):2895-2904. PubMed ID: 36422648
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.
Lee YS; Choi MH; Lee YJ; Han D; Kim DH
Br J Radiol; 2022 Mar; 95(1131):20210479. PubMed ID: 34415785
[TBL] [Abstract][Full Text] [Related]
11. Initial assessment of 3D magnetic resonance fingerprinting (MRF) towards quantitative brain imaging for radiation therapy.
Lu L; Chen Y; Shen C; Lian J; Das S; Marks L; Lin W; Zhu T
Med Phys; 2020 Mar; 47(3):1199-1214. PubMed ID: 31834641
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Evaluation of B
Kato Y; Ichikawa K; Okudaira K; Taoka T; Kawaguchi H; Murata K; Maruyama K; Koerzdoerfer G; Pfeuffer J; Nittka M; Naganawa S
Magn Reson Med Sci; 2020 Aug; 19(3):168-175. PubMed ID: 31217366
[TBL] [Abstract][Full Text] [Related]
13. Repeatability of magnetic resonance fingerprinting T
Jiang Y; Ma D; Keenan KE; Stupic KF; Gulani V; Griswold MA
Magn Reson Med; 2017 Oct; 78(4):1452-1457. PubMed ID: 27790751
[TBL] [Abstract][Full Text] [Related]
14. Development of high-resolution 3D MR fingerprinting for detection and characterization of epileptic lesions.
Ma D; Jones SE; Deshmane A; Sakaie K; Pierre EY; Larvie M; McGivney D; Blümcke I; Krishnan B; Lowe M; Gulani V; Najm I; Griswold MA; Wang ZI
J Magn Reson Imaging; 2019 May; 49(5):1333-1346. PubMed ID: 30582254
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Fingerprinting with short relaxation intervals.
Amthor T; Doneva M; Koken P; Sommer K; Meineke J; Börnert P
Magn Reson Imaging; 2017 Sep; 41():22-28. PubMed ID: 28666939
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance fingerprinting based comprehensive quantification of T1 and T2 values of the background prostatic peripheral zone: Correlation with clinical and demographic features.
de Oliveira Correia ET; Qiao PL; Griswold MA; Chen Y; Bittencourt LK
Eur J Radiol; 2023 Jul; 164():110883. PubMed ID: 37209463
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.
Sushentsev N; Kaggie JD; Slough RA; Carmo B; Barrett T
PLoS One; 2021; 16(1):e0245970. PubMed ID: 33513165
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance fingerprinting with quadratic RF phase for measurement of T
Wang CY; Coppo S; Mehta BB; Seiberlich N; Yu X; Griswold MA
Magn Reson Med; 2019 Mar; 81(3):1849-1862. PubMed ID: 30499221
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of MR fingerprinting using a high-performance 0.55 T MRI system.
Campbell-Washburn AE; Jiang Y; Körzdörfer G; Nittka M; Griswold MA
Magn Reson Imaging; 2021 Sep; 81():88-93. PubMed ID: 34116134
[TBL] [Abstract][Full Text] [Related]
20. T1, T2, and Fat Fraction Cardiac MR Fingerprinting: Preliminary Clinical Evaluation.
Jaubert O; Cruz G; Bustin A; Hajhosseiny R; Nazir S; Schneider T; Koken P; Doneva M; Rueckert D; Masci PG; Botnar RM; Prieto C
J Magn Reson Imaging; 2021 Apr; 53(4):1253-1265. PubMed ID: 33124081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
